VYNE - VYNE Therapeutics Inc.

QQQ $ 441.47 $ -1.45 (-0.33 %)

DIA $ 394.44 $ -0.80 (-0.2 %)

SPY $ 520.22 $ -1.30 (-0.25 %)

TLT $ 90.09 $ -0.22 (-0.24 %)

GLD $ 218.92 $ -0.86 (-0.39 %)

Previous Close

$ 2.65

Open

$ 2.76

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.76 - $ 2.76

52 Week Range

$ 1.67 - $ 7.88

Volume

42,984

Average Volume

Market Cap

112.84M

Beta (5Y Monthly)

$ 0.87

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-01-2024	12-31-2023	10-K
3	11-13-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-14-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-12-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-17-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	03-04-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-11-2020	03-31-2020	10-Q
18	03-03-2020	12-31-2019	10-K
19	10-31-2019	09-30-2019	10-Q
20	08-01-2019	06-30-2019	10-Q
21	05-02-2019	03-31-2019	10-Q
22	02-28-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-01-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	03-28-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on VYNE...
05/09/2024 15:27:59

HC Wainwright & Co. analyst Joseph Pantginis reiterates VYNE Therapeutics (NASDAQ:VYNE) with a Buy and maintains $5.75 p...

VYNE Therapeutics Q1 EPS $(0.15) Beats $(0...
05/09/2024 13:06:19

VYNE Therapeutics (NASDAQ:VYNE) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0...

HC Wainwright & Co. Reiterates Buy on VYNE...
05/06/2024 14:45:06

HC Wainwright & Co. analyst Joseph Pantginis reiterates VYNE Therapeutics (NASDAQ:VYNE) with a Buy and maintains $5.75 p...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
05/06/2024 12:06:38

VYNE Therapeutics Announces FDA Clearance ...
05/06/2024 12:04:29

VYNE Therapeutics Presents VYN201 At 2024 ...
05/01/2024 12:45:19

Presentations will highlight positive preclinical and Phase 1b data of novel BET inhibitor, VYN201, in nonsegmental vitiligo

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
03/29/2024 20:30:47

HC Wainwright & Co. Reiterates Buy on VYNE...
02/29/2024 20:06:04

HC Wainwright & Co. analyst Joseph Pantginis reiterates VYNE Therapeutics (NASDAQ:VYNE) with a Buy and maintains $5.75 p...

Recap: VYNE Therapeutics Q4 Earnings
02/29/2024 13:30:06

VYNE Therapeutics Ended 2023 With $93.3M O...
02/29/2024 13:12:41

VYNE Therapeutics Q4 Adjusted EPS $(0.18) ...
02/29/2024 13:12:15

VYNE Therapeutics (NASDAQ:VYNE) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0...

VYNE Therapeutics To Present Results Of Ph...
02/27/2024 13:14:38

Oral presentation on March 7, 2024 will review positive safety and efficacy data for novel BET inhibitor VYN201

top-4-health-care-stocks-that-may-rocket-higher-in-q1

Top 4 Health Care Stocks That May Rocket H...
01/16/2024 11:50:17

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.

why-richardson-electronics-shares-are-trading-lower-by-13-here-are-20-stocks-moving-premarket

Why Richardson Electronics Shares Are Trad...
01/11/2024 12:51:27

Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted wea...

VYNE Therapeutics Announces Biomarker Data...
01/10/2024 13:04:30

VYN201 demonstrated positive effect on key biomarkers relevant to vitiligoData supports VYN201's rapid onset of action and ...

VYNE Therapeutics Q3 Adj EPS $(1.59) Beats...
11/13/2023 12:50:08

VYNE Therapeutics (NASDAQ:VYNE) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(1...

Recap: VYNE Therapeutics Q3 Earnings
11/13/2023 12:50:05

dow-surges-over-500-points-western-digital-announces-plan-to-split-into-two-companies

Dow Surges Over 500 Points; Western Digita...
10/30/2023 19:06:49

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 500 points on Monday. The Dow ...

HC Wainwright & Co. Maintains Buy on VYNE ...
10/30/2023 18:59:51

HC Wainwright & Co. analyst Joseph Pantginis maintains VYNE Therapeutics (NASDAQ:VYNE) with a Buy and lowers the price t...

Why ON Semiconductor Shares Are Trading Lo...
10/30/2023 17:55:55

Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire...